Scienture reports preliminary Q3 revenue up 256% to $1.22 million, Arbli wholesale unit sales up 74%

Scienture Holdings (NASDAQ: SCNX) reported preliminary third-quarter revenue of approximately $1.22 million, up 256% from $344,000 in the prior quarter. Arbli wholesale unit sales rose 74% sequentially, with growth also reflecting initial wholesale shipments of Rezenopy, which launched in August 2026.

Detected & updated continuously · Source: Nebula